NCT07198516View on ClinicalTrials.gov

The Improvement Effect of Henggliejin on Fatty Liver in Type 2 Diabetes Patients With Nonalcoholic Fatty Liver:

EARLY_PHASE1Not yet recruitingINTERVENTIONAL

Enrollment

149

Participants

Timeline

Start Date

November 1, 2025

Primary Completion Date

September 1, 2026

Study Completion Date

December 31, 2026

Conditions

NAFLDDiabete Type 2

Interventions

DRUG

Addition of Hengge Liejing treatment for 48 weeks

Treatment with Hengge Liejing for 48 weeks, drug formulation: tablets. Dosage: 10mg qd, taken orally in the morning, before or after breakfast, for 48 consecutive weeks

All Listed Sponsors

lead

Fujian Medical University Union Hospital

OTHER